Emberi 6-os és 7-es herpeszvírusok szerepének szerológiai vizsgálata lymphomás betegekben.

Translated title of the contribution: Serologic study of human herpesviruses 6 and 7 in lymphoma patients

J. Ongrádi, P. Miheller, A. Csiszár, J. Menezes, C. L. Maródi, L. Sréter, A. Horváth

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

DNA sequences, antigens and elevated antibodies to HHV-6, and DNA sequences of HHV-7 in patients with Hodgkin's disease and non-Hodgkin's lymphoma have been detected. It is not known whether HHV-6 variants A and B, and HHV-7 contribute to the malignization by different ways, there is any interaction between these viruses, and their primary or recurrent infections occur during the disease progression. Total and high avidity IgG, IgM to HHV-6A, HHV-6B and HHV-7 were quantitated simultaneously in the sera of 12 patients with lymphomas and 12 control persons by indirect immunofluorescent assay and ELISA. It was established that, primary infection by HHV-6B in Hodgkin's disease, its primary or recurrent infections in non-Hodgkin's lymphoma; primary or recurrent infection by HHV-6A in Hodgkin's disease, its recurrent infection in non-Hodgkin's lymphoma; recurrent infection by HHV-7 in Hodgkin's disease may contribute to the deterioration of clinical conditions. Probably, HHV-7 exerts its effects through activating HHV-6B. The simultaneous effects of HHV-7 and HHV-6A, and that of HHV-6B and HHV-6A seem to be independent. Our results supports the recent opinion that, the effect of these herpesviruses on the tumorous cells is exerted indirectly by altered mediators of the immune system.

Original languageHungarian
Pages (from-to)1457-1459
Number of pages3
JournalOrvosi Hetilap
Volume140
Issue number26
Publication statusPublished - Jun 27 1999

Fingerprint

Human Herpesvirus 7
Human Herpesvirus 6
Lymphoma
Hodgkin Disease
Infection
Non-Hodgkin's Lymphoma
Herpesviridae
Immunoglobulin M
Disease Progression
Immune System

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Ongrádi, J., Miheller, P., Csiszár, A., Menezes, J., Maródi, C. L., Sréter, L., & Horváth, A. (1999). Emberi 6-os és 7-es herpeszvírusok szerepének szerológiai vizsgálata lymphomás betegekben. Orvosi Hetilap, 140(26), 1457-1459.

Emberi 6-os és 7-es herpeszvírusok szerepének szerológiai vizsgálata lymphomás betegekben. / Ongrádi, J.; Miheller, P.; Csiszár, A.; Menezes, J.; Maródi, C. L.; Sréter, L.; Horváth, A.

In: Orvosi Hetilap, Vol. 140, No. 26, 27.06.1999, p. 1457-1459.

Research output: Contribution to journalArticle

Ongrádi, J, Miheller, P, Csiszár, A, Menezes, J, Maródi, CL, Sréter, L & Horváth, A 1999, 'Emberi 6-os és 7-es herpeszvírusok szerepének szerológiai vizsgálata lymphomás betegekben.', Orvosi Hetilap, vol. 140, no. 26, pp. 1457-1459.
Ongrádi J, Miheller P, Csiszár A, Menezes J, Maródi CL, Sréter L et al. Emberi 6-os és 7-es herpeszvírusok szerepének szerológiai vizsgálata lymphomás betegekben. Orvosi Hetilap. 1999 Jun 27;140(26):1457-1459.
Ongrádi, J. ; Miheller, P. ; Csiszár, A. ; Menezes, J. ; Maródi, C. L. ; Sréter, L. ; Horváth, A. / Emberi 6-os és 7-es herpeszvírusok szerepének szerológiai vizsgálata lymphomás betegekben. In: Orvosi Hetilap. 1999 ; Vol. 140, No. 26. pp. 1457-1459.
@article{cdedf268e14d4a1c9f547865d5af486b,
title = "Emberi 6-os {\'e}s 7-es herpeszv{\'i}rusok szerep{\'e}nek szerol{\'o}giai vizsg{\'a}lata lymphom{\'a}s betegekben.",
abstract = "DNA sequences, antigens and elevated antibodies to HHV-6, and DNA sequences of HHV-7 in patients with Hodgkin's disease and non-Hodgkin's lymphoma have been detected. It is not known whether HHV-6 variants A and B, and HHV-7 contribute to the malignization by different ways, there is any interaction between these viruses, and their primary or recurrent infections occur during the disease progression. Total and high avidity IgG, IgM to HHV-6A, HHV-6B and HHV-7 were quantitated simultaneously in the sera of 12 patients with lymphomas and 12 control persons by indirect immunofluorescent assay and ELISA. It was established that, primary infection by HHV-6B in Hodgkin's disease, its primary or recurrent infections in non-Hodgkin's lymphoma; primary or recurrent infection by HHV-6A in Hodgkin's disease, its recurrent infection in non-Hodgkin's lymphoma; recurrent infection by HHV-7 in Hodgkin's disease may contribute to the deterioration of clinical conditions. Probably, HHV-7 exerts its effects through activating HHV-6B. The simultaneous effects of HHV-7 and HHV-6A, and that of HHV-6B and HHV-6A seem to be independent. Our results supports the recent opinion that, the effect of these herpesviruses on the tumorous cells is exerted indirectly by altered mediators of the immune system.",
author = "J. Ongr{\'a}di and P. Miheller and A. Csisz{\'a}r and J. Menezes and Mar{\'o}di, {C. L.} and L. Sr{\'e}ter and A. Horv{\'a}th",
year = "1999",
month = "6",
day = "27",
language = "Hungarian",
volume = "140",
pages = "1457--1459",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "26",

}

TY - JOUR

T1 - Emberi 6-os és 7-es herpeszvírusok szerepének szerológiai vizsgálata lymphomás betegekben.

AU - Ongrádi, J.

AU - Miheller, P.

AU - Csiszár, A.

AU - Menezes, J.

AU - Maródi, C. L.

AU - Sréter, L.

AU - Horváth, A.

PY - 1999/6/27

Y1 - 1999/6/27

N2 - DNA sequences, antigens and elevated antibodies to HHV-6, and DNA sequences of HHV-7 in patients with Hodgkin's disease and non-Hodgkin's lymphoma have been detected. It is not known whether HHV-6 variants A and B, and HHV-7 contribute to the malignization by different ways, there is any interaction between these viruses, and their primary or recurrent infections occur during the disease progression. Total and high avidity IgG, IgM to HHV-6A, HHV-6B and HHV-7 were quantitated simultaneously in the sera of 12 patients with lymphomas and 12 control persons by indirect immunofluorescent assay and ELISA. It was established that, primary infection by HHV-6B in Hodgkin's disease, its primary or recurrent infections in non-Hodgkin's lymphoma; primary or recurrent infection by HHV-6A in Hodgkin's disease, its recurrent infection in non-Hodgkin's lymphoma; recurrent infection by HHV-7 in Hodgkin's disease may contribute to the deterioration of clinical conditions. Probably, HHV-7 exerts its effects through activating HHV-6B. The simultaneous effects of HHV-7 and HHV-6A, and that of HHV-6B and HHV-6A seem to be independent. Our results supports the recent opinion that, the effect of these herpesviruses on the tumorous cells is exerted indirectly by altered mediators of the immune system.

AB - DNA sequences, antigens and elevated antibodies to HHV-6, and DNA sequences of HHV-7 in patients with Hodgkin's disease and non-Hodgkin's lymphoma have been detected. It is not known whether HHV-6 variants A and B, and HHV-7 contribute to the malignization by different ways, there is any interaction between these viruses, and their primary or recurrent infections occur during the disease progression. Total and high avidity IgG, IgM to HHV-6A, HHV-6B and HHV-7 were quantitated simultaneously in the sera of 12 patients with lymphomas and 12 control persons by indirect immunofluorescent assay and ELISA. It was established that, primary infection by HHV-6B in Hodgkin's disease, its primary or recurrent infections in non-Hodgkin's lymphoma; primary or recurrent infection by HHV-6A in Hodgkin's disease, its recurrent infection in non-Hodgkin's lymphoma; recurrent infection by HHV-7 in Hodgkin's disease may contribute to the deterioration of clinical conditions. Probably, HHV-7 exerts its effects through activating HHV-6B. The simultaneous effects of HHV-7 and HHV-6A, and that of HHV-6B and HHV-6A seem to be independent. Our results supports the recent opinion that, the effect of these herpesviruses on the tumorous cells is exerted indirectly by altered mediators of the immune system.

UR - http://www.scopus.com/inward/record.url?scp=0033609419&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033609419&partnerID=8YFLogxK

M3 - Article

VL - 140

SP - 1457

EP - 1459

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 26

ER -